1
Su1560 A Novel Forward-Viewing Radial-Array Echoendoscope With a New Application: Differentiation Between Ulcerative Colitis (UC) and Crohn’s Disease (CD) in Colon Beyond Rectum Satimai Aniwan*, Pradermchai Kongkam, Rungsun Rerknimitr, Sombat Treeprasertsuk, Wiriyaporn Ridtitid, Phonthep Angsuwatcharakon, Pinit Kullavanijaya Internal Medicine, Chulalongkorn University, Bangkok, Thailand Background: Colonoscopy has a limited capability to distinguish Crohn’s disease (CD) from ulcerative colitis (UC). CD has a characteristic trans-mural invasion through colonic wall. Endoscopic ultrasound (EUS), the best tool at present for intestinal wall delineation, is theoretically expected to be able to differentiate between these 2 diseases. Unfortunately, the current oblique-viewing radial-array EUS has a limitation in viewing and precludes deep intubation of EUS probe into the colon beyond rectum. With a newly designed forward-viewing radial-array echoendoscope (radial Scan Ultrasonic Video Endoscope EG-530UR2 (FUJIFILM Corporation, Tokyo, Japan) and Ultrasound Processor SU-8000 (FUJIFILM Corporation, Tokyo, Japan), the scope can readily be passed to the cecum and can be used to endosonographically illustrate colonic wall. At the time of writing we believe we are the first group to use this new equipment to study its efficacy in differentiating these 2 diseases. Methods: Patients with confirmed CD and UC in King Chulalongkorn Memorial hospital, Bangkok, Thailand, from 1st August to 31st October 2012, were prospectively recruited into the study. Both colonoscopy and colon EUS were performed. The endoscopic grading of severity was assessed by Baron Index for UC, and Crohn’s Disease Endoscopic Index of Severity for CD. EUS findings of total wall (TW) thickness, muscularis proria (MP) layer thickness, irregular interface between sub-mucosa (SM) and MP layer), from the most active colonic lesions were recorded and compared between the 2 groups. Results: Twenty-seven patients (8 CD, 19 UC) were enrolled. CD patients had significantly higher TW thickness (6.42.5 vs. 3.41.0 mm; p0.001), SM wall thickness (2.41.4 vs. 1.40.5 mm; p0.015), and MP wall thickness (2.31.6 vs. 1.00.4 mm; p0.003) than UC patients. Irregular interface between SM and MP layer was detected in 63% of CD patients, whereas none of the UC patients was detected. Fusion of all 5 layers was demonstrated in 2 patients with CD. Summary: The new forward-viewing radial-array echoendoscope demonstrated significantly thicker colonic wall in CD than UC. It also shows a characteristic fusion of all 5 layers in CD. Conclusion: The new forward-viewing radial-array echoendoscope is a promising tool for differentiating CD from UC. We will conduct a larger systematic study to validate the real accuracy and usefulness of this new equipment. Table 1. EUS parameters between CD patients and UC patients EUS parameters CD (n8) UC (n19) P value Total wall thickness (mm) 6.42.5 3.41.0 p0.001 Submucosal layer thickness (mm) 2.41.4 1.40.5 p0.015 Muscularis propria layer thickness (mm) 2.31.6 1.00.4 p0.003 Irregular interface between submucosa and muscularis propria layer (number and %) 5(63%) 0(0%) p0.001 Su1561 Endoscopic Ultrasound of the Colon for Evaluation of Mucosal Healing/Early Therapy Response of Anti-TNF- Therapy in Patients With Ulcerative Colitis - First Results of a Pilot Study Mark Ellrichmann*, Johannes Bethge, Susanna Nikolaus, Alexander Arlt, Stefan Schreiber, Annette Fritscher-Ravens Experimental Endoscopy, Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany Introduction: Evaluation of mucosal healing in acute ulcerative colitis (aUC) is important, but the assessment of inflammatory changes is based on a combination of clinical, endoscopic and histological activity indices, which often fail to deliver early information about therapy response. In an earlier study we demonstrated that Endoscopic ultrasound of the colonic wall (EUSc) allows exact quantification of the total wall thickness (TWT), differentiation of the different layers and can therefore accurately quantify the grade of inflammation. Aim: To evaluate EUSc in patients with aUC undergoing treatment with Anti-TNF- (adalimumab,(AD)) for possible detection of early therapy response. Methods: Eleven consecutive patients with aUC were examined prior and 1, 4 and 12 weeks after initiation of AD-therapy using forward-viewing radial echoendoscope (Pentax-Hitachi, Japan). Mucosal, submucosal and total wall-thickness (TWT) were measured by EUSc in the mid sigmoid. Results were compared to 10 healthy controls (HC) undergoing screening colonoscopy. The examiners were blinded to the macroscopic inflammation scores. EUS-results were correlated to the Mayo-score and histological inflammation scores (HIS). Results: TWT in HC was 1.710.02mm with clear differentiation of the different layers; in aUC it was 3.40.87mm (p0.001). In patients with clinical response to therapy (n10) TWT was reduced by 27.9% (TWT7d2.50.2mm; p0.01) within one week when compared to baseline levels. In contrast, Mayo scores (2.1) did not show a reduction in this period (Mayobaseline2.2). After 4 weeks a further reduction of (12%) of TWT (TWT28d2.20.2mm) was observed, then accompanied by significant reduction of the Mayo-score (Mayo28d1.20.2). Prior to therapy there was a strong correlation of TWT and Mayo-score. In contrast, no correlation was observed 1 week after AD-therapy (p0.05). During the entire course of AD, a positive relation between TWT and HIS (r0.65; p0.001) was seen.In one patient no reduction of the TWT was observed within 1 week of therapy. This patient was defined to be a non-responder to AD-therapy 6 weeks later. Discussion: TWT measured by EUSc precisely quantifies the level of inflammation in patients with aUC and proved reliable for the evaluation of early therapy response. It may become an important diagnostic tool for the judgement of mucosal healing in AD-therapy. Su1562 A Novel Forward-Viewing Radial-Array Echoendoscope With a New Application: T Staging of Colon Cancer Beyond Rectum: a Prospective Blinded Feasibility Study Sittikorn Linlawan* 1 , Pradermchai Kongkam 1 , Rungsun Rerknimitr 1 , Chucheep Sahakitrungruang 2 , Jirawat Pattana-Arun 2 , Supakij Khomvilai 2 , Naruemon Wisedopas 3 , Narisorn Lakananurak 1 , Satimai Aniwan 1 , Wiriyaporn Ridtitid 1 , Pinit Kullavanijaya 1 1 Internal medicine, Chulalongkorn university, Bangkok, Thailand; 2 Surgery, Chulalongkorn university, Bangkok, Thailand; 3 Pathology, Chulalongkorn university, Bangkok, Thailand Introduction: Preoperative T staging of rectal cancer can be accurately performed by a transrectal endoscopic ultrasound (EUS). Several past studies confirmed its superiority over CT scan. Unfortunately, current oblique endoscopic viewing radial-array EUS has a limitation of endoscopic view and precludes deep intubation of EUS probe into colon beyond rectum. With a newly designed forward-viewing radial-array echoendoscope (radial Scan Ultrasonic Video Endoscope EG-530UR2 (FUJIFILM Corporation, Tokyo, Japan) and Ultrasound Figure 1. Surgical Pathology Results for 34 Patients with EUS Diagnosis of T2N0 Rectal Cancer Abstracts AB368 GASTROINTESTINAL ENDOSCOPY Volume 77, No. 5S : 2013 www.giejournal.org

Su1561 Endoscopic Ultrasound of the Colon for Evaluation of Mucosal Healing/Early Therapy Response of Anti-TNF-α Therapy in Patients With Ulcerative Colitis - First Results of a Pilot

  • Upload
    annette

  • View
    213

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Su1561 Endoscopic Ultrasound of the Colon for Evaluation of Mucosal Healing/Early Therapy Response of Anti-TNF-α Therapy in Patients With Ulcerative Colitis - First Results of a Pilot

Su1560A Novel Forward-Viewing Radial-Array Echoendoscope With aNew Application: Differentiation Between Ulcerative Colitis (UC)and Crohn’s Disease (CD) in Colon Beyond RectumSatimai Aniwan*, Pradermchai Kongkam, Rungsun Rerknimitr,Sombat Treeprasertsuk, Wiriyaporn Ridtitid,Phonthep Angsuwatcharakon, Pinit KullavanijayaInternal Medicine, Chulalongkorn University, Bangkok, ThailandBackground: Colonoscopy has a limited capability to distinguish Crohn’s disease(CD) from ulcerative colitis (UC). CD has a characteristic trans-mural invasionthrough colonic wall. Endoscopic ultrasound (EUS), the best tool at present forintestinal wall delineation, is theoretically expected to be able to differentiatebetween these 2 diseases. Unfortunately, the current oblique-viewing radial-arrayEUS has a limitation in viewing and precludes deep intubation of EUS probe intothe colon beyond rectum. With a newly designed forward-viewing radial-arrayechoendoscope (radial Scan Ultrasonic Video Endoscope EG-530UR2 (FUJIFILMCorporation, Tokyo, Japan) and Ultrasound Processor SU-8000 (FUJIFILMCorporation, Tokyo, Japan), the scope can readily be passed to the cecum andcan be used to endosonographically illustrate colonic wall. At the time of writingwe believe we are the first group to use this new equipment to study its efficacyin differentiating these 2 diseases. Methods: Patients with confirmed CD and UCin King Chulalongkorn Memorial hospital, Bangkok, Thailand, from 1st August to31st October 2012, were prospectively recruited into the study. Bothcolonoscopy and colon EUS were performed. The endoscopic grading of severitywas assessed by Baron Index for UC, and Crohn’s Disease Endoscopic Index ofSeverity for CD. EUS findings of total wall (TW) thickness, muscularis proria(MP) layer thickness, irregular interface between sub-mucosa (SM) and MPlayer), from the most active colonic lesions were recorded and comparedbetween the 2 groups. Results: Twenty-seven patients (8 CD, 19 UC) wereenrolled. CD patients had significantly higher TW thickness (6.4�2.5 vs. 3.4�1.0mm; p�0.001), SM wall thickness (2.4�1.4 vs. 1.4�0.5 mm; p�0.015), and MPwall thickness (2.3�1.6 vs. 1.0�0.4 mm; p�0.003) than UC patients. Irregularinterface between SM and MP layer was detected in 63% of CD patients, whereasnone of the UC patients was detected. Fusion of all 5 layers was demonstrated in2 patients with CD. Summary: The new forward-viewing radial-arrayechoendoscope demonstrated significantly thicker colonic wall in CD than UC. Italso shows a characteristic fusion of all 5 layers in CD. Conclusion: The newforward-viewing radial-array echoendoscope is a promising tool fordifferentiating CD from UC. We will conduct a larger systematic study to validatethe real accuracy and usefulness of this new equipment.

Table 1. EUS parameters between CD patients and UC patients

EUS parametersCD

(n�8)UC

(n�19) P value

Total wall thickness (mm) 6.4�2.5 3.4�1.0 p�0.001Submucosal layer thickness (mm) 2.4�1.4 1.4�0.5 p�0.015Muscularis propria layer thickness

(mm)2.3�1.6 1.0�0.4 p�0.003

Irregular interface betweensubmucosa and muscularispropria layer (number and %)

5(63%) 0(0%) p�0.001

Su1561Endoscopic Ultrasound of the Colon for Evaluation of MucosalHealing/Early Therapy Response of Anti-TNF-� Therapy inPatients With Ulcerative Colitis - First Results of a Pilot StudyMark Ellrichmann*, Johannes Bethge, Susanna Nikolaus, Alexander Arlt,Stefan Schreiber, Annette Fritscher-RavensExperimental Endoscopy, Internal Medicine I, University HospitalSchleswig-Holstein, Campus Kiel, Kiel, GermanyIntroduction: Evaluation of mucosal healing in acute ulcerative colitis (aUC) isimportant, but the assessment of inflammatory changes is based on acombination of clinical, endoscopic and histological activity indices, which oftenfail to deliver early information about therapy response. In an earlier study wedemonstrated that Endoscopic ultrasound of the colonic wall (EUSc) allows exactquantification of the total wall thickness (TWT), differentiation of the differentlayers and can therefore accurately quantify the grade of inflammation. Aim: Toevaluate EUSc in patients with aUC undergoing treatment with Anti-TNF-�(adalimumab,(AD)) for possible detection of early therapy response. Methods:Eleven consecutive patients with aUC were examined prior and 1, 4 and 12weeks after initiation of AD-therapy using forward-viewing radial echoendoscope(Pentax-Hitachi, Japan). Mucosal, submucosal and total wall-thickness (TWT)were measured by EUSc in the mid sigmoid. Results were compared to 10healthy controls (HC) undergoing screening colonoscopy. The examiners wereblinded to the macroscopic inflammation scores. EUS-results were correlated tothe Mayo-score and histological inflammation scores (HIS). Results: TWT in HCwas 1.71�0.02mm with clear differentiation of the different layers; in aUC it was3.4�0.87mm (p�0.001). In patients with clinical response to therapy (n�10)TWT was reduced by 27.9% (TWT7d�2.5�0.2mm; p�0.01) within one weekwhen compared to baseline levels. In contrast, Mayo scores (2.1) did not show areduction in this period (Mayobaseline�2.2). After 4 weeks a further reductionof (12%) of TWT (TWT28d�2.2�0.2mm) was observed, then accompanied bysignificant reduction of the Mayo-score (Mayo28d�1.2�0.2). Prior to therapythere was a strong correlation of TWT and Mayo-score. In contrast, nocorrelation was observed 1 week after AD-therapy (p�0.05). During the entirecourse of AD, a positive relation between TWT and HIS (r�0.65; p�0.001) wasseen.In one patient no reduction of the TWT was observed within 1 week oftherapy. This patient was defined to be a non-responder to AD-therapy 6 weekslater. Discussion: TWT measured by EUSc precisely quantifies the level ofinflammation in patients with aUC and proved reliable for the evaluation of earlytherapy response. It may become an important diagnostic tool for the judgementof mucosal healing in AD-therapy.

Su1562A Novel Forward-Viewing Radial-Array Echoendoscope With aNew Application: T Staging of Colon Cancer Beyond Rectum: aProspective Blinded Feasibility StudySittikorn Linlawan*1, Pradermchai Kongkam1, Rungsun Rerknimitr1,Chucheep Sahakitrungruang2, Jirawat Pattana-Arun2,Supakij Khomvilai2, Naruemon Wisedopas3, Narisorn Lakananurak1,Satimai Aniwan1, Wiriyaporn Ridtitid1, Pinit Kullavanijaya1

1Internal medicine, Chulalongkorn university, Bangkok, Thailand;2Surgery, Chulalongkorn university, Bangkok, Thailand; 3Pathology,Chulalongkorn university, Bangkok, ThailandIntroduction: Preoperative T staging of rectal cancer can be accurately performedby a transrectal endoscopic ultrasound (EUS). Several past studies confirmed itssuperiority over CT scan. Unfortunately, current oblique endoscopic viewingradial-array EUS has a limitation of endoscopic view and precludes deepintubation of EUS probe into colon beyond rectum. With a newly designedforward-viewing radial-array echoendoscope (radial Scan Ultrasonic VideoEndoscope EG-530UR2 (FUJIFILM Corporation, Tokyo, Japan) and Ultrasound

Figure 1. Surgical Pathology Results for 34 Patients with EUS Diagnosisof T2N0 Rectal Cancer

Abstracts

AB368 GASTROINTESTINAL ENDOSCOPY Volume 77, No. 5S : 2013 www.giejournal.org